The phase II project of the University of Hong Kong-Shenzhen Hospital (HKU-SZH) has been initially launched and is planned to be completed by the end of 2024, HKU-SZH disclosed at a press conference on the 8th anniversary of its founding, yesterday.

The project, an emphasis on the hospital’s development plan in the next five years, includes an inpatient building that will accommodate 1,000 hospital beds and prioritize the provision of medical services of pediatrics and oncology. The new building will be put into use in early 2025, the hospital said.

According to the hospital’s plan, the phase II project will set up shared medical departments such as operating rooms, intensive care units, and an endoscopy center, establish a multi-disciplinary children’s center and cancer center, and integrate the characteristic medical resources of the hospital.

“We are thrilled to be working with AXA Hong Kong in bringing a quality service experience to patients. HKU-SZH will establish four international centers for the Greater Bay Area, including the International Medical Centre, Medical Talent Training Centre, Medical Science and Technology Innovation Centre, and Hospital Management Innovation Centre, to advance and promote the integration of medical service, teaching, research, and management. The mission of HKU-SZH is not only to be a ‘first-class nationally and renowned internationally’ hospital, but also to become a world-leading teaching hospital and medical faculty serving as a cradle for grooming medical talent in China,”

said Professor Chung-Mau Lo, Chief Executive of the University of Hong Kong-Shenzhen Hospital.

Additionally, the scientific research building of the phase II project will encompass a clinical trial center, a bioinformatics laboratory, an artificial intelligence platform, a digital medical platform, a tissue sample bank, an animal laboratory, and a preclinical animal experiment evaluation center, according to the hospital’s plan.

Over the next five years, HKU-SZH will introduce research teams from the University of Hong Kong to build a clinical and translational medicine research center in the planned Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone.

To meet citizens’ demand for high-end medical services, the hospital’s International Medical Center (IMC) will continue to provide new services.

About University of Hong Kong-Shenzhen Hospital

Fully funded by the Municipal Government of Shenzhen, HKU-SZ Hospital is a large public general hospital running on HKU’s modern management mode. With a 367,000 sq. m floor area within a 192,000 sq. m. compound, the RMB 4 billion Complex is home to 2,000 beds, and will be to 3,000 beds upon the completion of its ongoing Phase-II Project.

Seizing the rare opportunity of deepening Hong Kong-Shenzhen cooperation, it set up and operates 6 medical centers based on major specialties of top-class international caliber in HKU: Reproductive Medicine & Prenatal Diagnosis, Comprehensive Cancer Treatment, Cardiovascular Therapy, Orthopedics & Traumatology, Organ Transplantation, and Infectious Diseases.

In addition, it also operates an International Medical Center (IMC), offering quality medical services of advanced world standards.

It was fully accredited by the Australian Council of Healthcare Standard (ACHS) in September 2015, promoted to be a Grade III Level A national general hospital in November 2017, and selected among the Guangdong’s Advanced Hospitals Under Development in June 2018.

The international Medical Center was established by HKU-SZH to offer high-end quality patient-centered healthcare services of international standards to better satisfy and diversified needs of patients from both China and abroad.

With over 200 beds in single deluxe or VIP suites, IMC boasts a strong professional force, consisting of consultants of professor standing from HKU and other advanced countries, as well as senior doctors in Mainland of China. It is designed to provide local and foreigner with high-quality and accessible healthcare service.


Write A Comment